LABETALOL Gene Set

Dataset DGIdb Drug Targets 2026
Category physical interactions
Type drug
Description A secondary amino compound formally derived from ammonia by replacing two of the hydrogens by 2-(3-carbamoyl-4-hydroxyphenyl)-2-hydroxyethyl and 4-phenylbutan-2-yl groups. It is an adrenergic antagonist used to treat high blood pressure. (Chemical Entities of Biological Interest Ontology, CHEBI_6343)
External Link https://dgidb.org/results?searchType=drug&searchTerms=LABETALOL
Similar Terms
Downloads & Tools

Genes

17 interacting proteins for the LABETALOL drug from theDGIdb Drug Targets 2026 dataset.

Symbol Name Standardized Value
GJA1 gap junction protein, alpha 1, 43kDa 0.415153
HPSE heparanase 0.327752
GRK4 G protein-coupled receptor kinase 4 0.222403
LPL lipoprotein lipase 0.194603
UGT1A1 UDP glucuronosyltransferase 1 family, polypeptide A1 0.124546
GRK5 G protein-coupled receptor kinase 5 0.11532
ADRB1 adrenoceptor beta 1 0.0929447
ADRB2 adrenoceptor beta 2, surface 0.0707647
ADRA1A adrenoceptor alpha 1A 0.067201
ADRA1B adrenoceptor alpha 1B 0.0593076
ADRA1D adrenoceptor alpha 1D 0.058199
CYP2C19 cytochrome P450, family 2, subfamily C, polypeptide 19 0.0261102
ADRA2C adrenoceptor alpha 2C 0.0253142
CYP2C9 cytochrome P450, family 2, subfamily C, polypeptide 9 0.0142828
CYP1A2 cytochrome P450, family 1, subfamily A, polypeptide 2 0.0106632
CYP2D6 cytochrome P450, family 2, subfamily D, polypeptide 6 0.010192
CYP3A4 cytochrome P450, family 3, subfamily A, polypeptide 4 0.00702855